Brasada Capital Management, LP Becton Dickinson & CO Transaction History

Brasada Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $1.6 Million - $1.84 Million	-6,871 Reduced 42.98%	9,115 $2.22 Million
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $4.07 Million - $4.53 Million	15,986 New	15,986 $4.13 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $25,515 - $132,115	500 Added 22.22%	2,750 $613,000
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $528,165 - $619,695	2,250 New	2,250 $555,000
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $489,225 - $697,525	-2,500 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$236.45 - $266.82 $59,112 - $66,705	250 Added 11.11%	2,500 $680,000
Q3 2019 Nov 04, 2019	BUY	$230.58 - $256.08 $518,805 - $576,180	2,250 New	2,250 $569,000
Q1 2019 May 06, 2019	SELL	$206.05 - $248.17 $4,327 - $5,211	-21 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$233.07 - $256.0 $4,894 - $5,376	21 New	21 $5,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Brasada Capital Management, LP with notifications on news.